Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil
Laryngismus
About this trial
This is an interventional other trial for Laryngismus focused on measuring laryngeal mask airway, insertion, sevoflurane, remifentanil
Eligibility Criteria
Inclusion Criteria:
- Adult patients, aged 18-60 with ASA physical status I or II, who were scheduled to minor elective surgery (< 1 h) were considered for the study
Exclusion Criteria:
- Exclusion criteria were allergies to the study drugs, a history of gastric reflux, a history of drug abuse, obesity (body mass index > 30 kg/m2) and suspected difficult airway
Sites / Locations
- Ajou University School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Active Comparator
Active Comparator
Control
Remifentanil 1
Remifentanil 2
The control group, which received an infusion of normal saline.
"Remifentanil 1": "The R1 group, which received a target effect-site remifentanil concentration of 1 ng/ml.
"Remifentanil 2": "The R2 group, which received a target effect-site remifentanil concentration of 2 ng/ml.